USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $-0.48 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $0.00 |
Aprea Therapeutics, Inc's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 5 | $-1.57 | $-2.02 | $-1.25 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 0 | $-1.63 | $-1.63 | $-1.63 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 5 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 5, 2022 | Mar 2022 | $-0.36 | - | - |
| Mar 15, 2022 | Dec 2021 | $-0.44 | $-0.36 | 18.18% |
| Nov 8, 2021 | Sep 2021 | $-0.45 | $-0.45 | 0.40% |
| Aug 12, 2021 | Jun 2021 | $-0.47 | $-0.48 | -2.43% |
| May 6, 2021 | Mar 2021 | $-0.49 | $-0.46 | 6.50% |
| Mar 16, 2021 | Dec 2020 | $-0.64 | $-0.73 | -13.71% |
| Nov 5, 2020 | Sep 2020 | $-0.76 | $-0.58 | 23.73% |
| Aug 11, 2020 | Jun 2020 | $-0.60 | $-0.78 | -29.46% |
| May 15, 2020 | Mar 2020 | $-0.57 | $-0.45 | 20.70% |
| Mar 26, 2020 | Dec 2019 | $-0.41 | $-0.64 | -56.06% |
| Nov 14, 2019 | Sep 2019 | $-5.67 | $-5.29 | 6.76% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 15, 2022 | Dec 2021 | $-1.74 | $-1.75 | - |
| Mar 16, 2021 | Dec 2020 | $-2.43 | $-2.54 | - |
| Mar 26, 2020 | Dec 2019 | $-2.87 | $-5.93 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 5, 2022 | Mar 2022 | $0.00 | - | - |
| Mar 15, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 5, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 15, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 14, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 15, 2022 | Dec 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $0.00 | - |
APRE's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.
Aprea Therapeutics, Inc's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.
Aprea Therapeutics, Inc's previous annual earnings date was Mar 15, 2022 for its fiscal year ended Dec 31, 2021.
APRE's earnings per share (EPS) was $-1.75, missing the consensus analysts forecast of $-1.74 by 0.57% , and higher than the previous year's EPS (Dec 2020) by -31.10%.
Revenues were $0.00.
The company reported a net income of $-37.13B.
Aprea Therapeutics, Inc reported a free cash flow of $-37.69M for its fiscal year, compared to $-41.83M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
